[Current status, challenges and strategy of combination treatment of local interventional therapy and immunotherapy for primary hepatocellular carcinoma].

Hu, H T; Guo, C Y; Zhao, X H; Li, H L

Hu, H T; Guo, C Y; Zhao, X H; Li, H L.

Afiliación

Hu HT; Department of Minimally Interventional Radiology, the Affiliated Cancer Hospital of zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
Guo CY; Department of Minimally Interventional Radiology, the Affiliated Cancer Hospital of zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
Zhao XH; Department of Minimally Interventional Radiology, the Affiliated Cancer Hospital of zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
Li HL; Department of Minimally Interventional Radiology, the Affiliated Cancer Hospital of zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.

Zhonghua Nei Ke Za Zhi ; 61(5): 455-459, 2022 May 01.

Article en Zh | MEDLINE | ID: mdl-35488591

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Carcinoma Hepatocelular/terapia; Humanos; Factores Inmunológicos; Inmunoterapia; Neoplasias Hepáticas/terapia; Investigación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google